Outcomes in hormone-refractory prostate cancer are very poor. The time from progression to death is only 12-19 months. We present the case of a 69-year-old man with hormone-refractory prostate cancer and bone metastases treated with metronomic chemotherapy (cyclophosphamide based). He had had a colon adenocarcinoma ten years before. The atypical features of this case were an unusually long-lasting response to metronomic chemotherapy and an increase in serum levels of some non-prostate-specific tumor markers (CEA and CA 19-9) that was not related to a relapse of colon cancer. We hypothesize a potential role of hypoxia inducing CA 19-9 and CEA expression in tumor cells, which may predict the development of progressive resistance to antiangiogenic therapies

Massaccesi, M., Forni, F., Spagnuolo, R., Macchia, G., Mignogna, S., De Ninno, M., Cellini, N., Giardina, B., Carbone, A., Morganti, A. G., Multiple tumor marker elevation in androgen ablation-refractory prostate cancer with long-term response to metronomic chemotherapy: a case report, <<THE INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS>>, 2010; 2010 (Ottobre): 243-247 [http://hdl.handle.net/10807/12365]

Multiple tumor marker elevation in androgen ablation-refractory prostate cancer with long-term response to metronomic chemotherapy: a case report

Massaccesi, Mariangela;Forni, Franca;Spagnuolo, Rocco;Macchia, Gabriella;Mignogna, Samantha;De Ninno, Maria;Cellini, Numa;Giardina, Bruno;Carbone, Arnaldo;Morganti, Alessio Giuseppe
2010

Abstract

Outcomes in hormone-refractory prostate cancer are very poor. The time from progression to death is only 12-19 months. We present the case of a 69-year-old man with hormone-refractory prostate cancer and bone metastases treated with metronomic chemotherapy (cyclophosphamide based). He had had a colon adenocarcinoma ten years before. The atypical features of this case were an unusually long-lasting response to metronomic chemotherapy and an increase in serum levels of some non-prostate-specific tumor markers (CEA and CA 19-9) that was not related to a relapse of colon cancer. We hypothesize a potential role of hypoxia inducing CA 19-9 and CEA expression in tumor cells, which may predict the development of progressive resistance to antiangiogenic therapies
2010
Inglese
Massaccesi, M., Forni, F., Spagnuolo, R., Macchia, G., Mignogna, S., De Ninno, M., Cellini, N., Giardina, B., Carbone, A., Morganti, A. G., Multiple tumor marker elevation in androgen ablation-refractory prostate cancer with long-term response to metronomic chemotherapy: a case report, <<THE INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS>>, 2010; 2010 (Ottobre): 243-247 [http://hdl.handle.net/10807/12365]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/12365
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact